ArticleJournal of thrombosis and thrombolysis2023

Profibrinolytic effects of rivaroxaban are mediated by thrombin-activatable fibrinolysis inhibitor and are attenuated by a naturally occurring stabilizing mutation in enzyme.

Justin J W Garabon et al.PubMed ↗Publisher ↗

No numbers read from the abstract.